Remove Blogging Remove Incubator Remove Patents Remove Seed Funding
article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5

article thumbnail

Frank Addantes FounderBlog: Startup 5.0 – I’m just going to chill out for a bit… (OK, for a month…)

Frank Addante

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! Incubation 3. Venture Capital Funding 7. ► October (1) New Video! StrongMail Systems, Inc.

Startup 40